Your browser is no longer supported. Please, upgrade your browser.
Settings
CHRS Coherus BioSciences, Inc. daily Stock Chart
CHRS [NASD]
Coherus BioSciences, Inc.
Index- P/E- EPS (ttm)-0.19 Insider Own0.60% Shs Outstand70.04M Perf Week-14.71%
Market Cap1.34B Forward P/E8.12 EPS next Y2.36 Insider Trans-67.97% Shs Float64.77M Perf Month1.59%
Income-12.00M PEG- EPS next Q0.73 Inst Own- Short Float17.02% Perf Quarter-0.23%
Sales232.20M P/S5.79 EPS this Y28.20% Inst Trans6.18% Short Ratio10.50 Perf Half Y-12.37%
Book/sh0.80 P/B23.99 EPS next Y59.51% ROA-5.60% Target Price32.57 Perf Year36.78%
Cash/sh2.43 P/C7.88 EPS next 5Y23.00% ROE191.30% 52W Range12.95 - 23.91 Perf YTD6.58%
Dividend- P/FCF- EPS past 5Y-14.00% ROI- 52W High-23.02% Beta3.04
Dividend %- Quick Ratio3.20 Sales past 5Y- Gross Margin96.00% 52W Low42.12% ATR0.98
Employees272 Current Ratio3.30 Sales Q/Q- Oper. Margin1.00% RSI (14)36.64 Volatility5.05% 4.50%
OptionableYes Debt/Eq3.18 EPS Q/Q169.10% Profit Margin-5.20% Rel Volume1.70 Prev Close19.19
ShortableYes LT Debt/Eq3.18 EarningsFeb 27 AMC Payout- Avg Volume1.05M Price18.41
Recom1.70 SMA20-11.22% SMA50-5.00% SMA200-4.77% Volume1,360,049 Change-4.09%
Aug-13-19Initiated Mizuho Buy
Aug-02-19Reiterated Maxim Group Buy $25 → $27
Aug-02-19Reiterated H.C. Wainwright Buy $28 → $29
Jun-11-19Initiated Barclays Overweight $30
May-07-19Initiated H.C. Wainwright Buy $28
Aug-28-18Initiated H.C. Wainwright Buy $28
Mar-09-18Reiterated Maxim Group Buy $20 → $15
Aug-08-17Reiterated JP Morgan Overweight $32 → $25
Jun-13-17Reiterated Maxim Group Buy $44 → $40
May-05-17Initiated BMO Capital Markets Outperform $54
Oct-19-16Initiated Robert W. Baird Outperform $40
Sep-07-16Initiated Maxim Group Buy $43
Jul-27-16Initiated Citigroup Buy $36
Jan-20-16Initiated Credit Suisse Outperform
Feb-27-20 04:01PM  Coherus BioSciences Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire -5.84%
Feb-26-20 09:30AM  Coherus BioSciences Management to Present at the 40th Annual Cowen Healthcare Conference GlobeNewswire
Feb-24-20 09:43AM  Coherus (CHRS) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-20-20 11:19AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Feb-11-20 11:30AM  Has Coherus BioSciences (CHRS) Outpaced Other Medical Stocks This Year? Zacks
Feb-07-20 12:00PM  Coherus BioSciences (CHRS) Upgraded to Strong Buy: Here's Why Zacks +5.92%
Feb-06-20 09:34AM  Coherus BioSciences to Report Fourth Quarter and Full Year Financial Results on February 27th GlobeNewswire
Jan-23-20 11:30AM  Has Coherus BioSciences (CHRS) Outpaced Other Medical Stocks This Year? Zacks
Jan-17-20 08:16AM  Arena's (ARNA) Heart Failure Candidate Gets Fast Track Status Zacks
Jan-13-20 08:30AM  Coherus Acquires Commercial Rights for Avastin® Biosimilar in the United States GlobeNewswire
Jan-08-20 08:53AM  Amarin Posts '19 Preliminary Results, Gives 2020 Expense View Zacks
Jan-07-20 11:30AM  Is Coherus BioSciences (CHRS) Stock Outpacing Its Medical Peers This Year? Zacks
09:59AM  Protagonist (PTGX) Starts Study on PTG-300 for Blood Disorder Zacks
Jan-03-20 09:55AM  Pulmatrix Surges on License Agreement With Johnson & Johnson Zacks
09:30AM  Coherus BioSciences Management to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
09:01AM  Arena (ARNA) Expands Strategic Deal With Beacon Discovery Zacks
Dec-30-19 09:44AM  Flexion's (FLXN) Stock Up on FDA Approval for Zilretta sNDA Zacks
Dec-19-19 11:30AM  Has Coherus BioSciences (CHRS) Outpaced Other Medical Stocks This Year? Zacks
Dec-16-19 09:34AM  5 Biotech Stocks Set for Continued Rally in 2020 Zacks
Dec-07-19 12:25PM  Is Coherus Biosciences Inc (CHRS) A Good Stock To Buy ? Insider Monkey
Dec-03-19 08:51AM  Top Ranked Momentum Stocks to Buy for December 3rd Zacks -5.26%
Nov-26-19 11:27AM  Top Ranked Momentum Stocks to Buy for November 26th Zacks -7.77%
Nov-19-19 09:36AM  Alkermes to Acquire Rodin Therapeutics, Boost CNS Pipeline Zacks
Nov-15-19 11:17PM  Edited Transcript of CHRS earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
10:08AM  Breakout Stocks & Technical Analysis Investor's Business Daily
Nov-12-19 09:30AM  Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences GlobeNewswire
08:18AM  The Zacks Analyst Blog Highlights: Coherus, Incyte, ACADIA and Celgene Zacks
Nov-11-19 09:28AM  4 Biotech Stocks That Could Keep Beating Wall Street Zacks
Nov-08-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Nov-06-19 06:15PM  Coherus BioSciences (CHRS) Q3 Earnings and Revenues Surpass Estimates Zacks
04:01PM  Coherus BioSciences Reports Corporate Highlights and Third Quarter 2019 Financial Results GlobeNewswire
04:01PM  Coherus Acquires Commercial Rights for Leading Lucentis Biosimilar in the United States GlobeNewswire
Oct-29-19 03:16PM  Investors Can Find Strong Stocks with our First Profit Screen Zacks +5.23%
Oct-28-19 11:18AM  3 Perfect 10 Biotech Stocks to Buy Amid Volatile Market Environment TipRanks
Oct-26-19 01:22PM  Hedge Funds Have Never Been More Bullish On Coherus Biosciences Inc (CHRS) Insider Monkey
Oct-21-19 07:44AM  Are Insiders Selling Coherus BioSciences, Inc. (NASDAQ:CHRS) Stock? Simply Wall St.
Oct-18-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Oct-15-19 09:30AM  Coherus BioSciences to Report Third Quarter Financial Results on November 6th GlobeNewswire +5.00%
Sep-25-19 04:37PM  How This IBD Stock Of The Day Is Rattling Medical Giants Amgen, Mylan Investor's Business Daily
Sep-20-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire +5.69%
Sep-10-19 03:18PM  Investors Can Find Big Returns with this First Profit Screen Zacks
09:00AM  Coherus BioSciences (CHRS) Upgraded to Buy: Here's What You Should Know Zacks
Sep-04-19 11:51AM  Edited Transcript of CHRS earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-28-19 04:05PM  Stocks To Watch: Is Biosimilars Leader Coherus Biosciences Set To Rebound? Investor's Business Daily
Aug-22-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
09:11AM  Is Coherus BioSciences (NASDAQ:CHRS) Using Too Much Debt? Simply Wall St.
Aug-21-19 09:30AM  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in September GlobeNewswire +9.22%
Aug-01-19 07:52PM  Coherus BioSciences, Inc. (CHRS) Q2 2019 Earnings Call Transcript Motley Fool
06:55PM  Coherus BioSciences (CHRS) Beats Q2 Earnings and Revenue Estimates Zacks
04:00PM  Coherus BioSciences Reports Corporate Highlights and Second Quarter 2019 Financial Results GlobeNewswire
Jul-31-19 01:48PM  Steven Cohen Charges Into Chiasma GuruFocus.com
Jul-29-19 08:30PM  Coherus BioSciences Reports Victory in Pegfilgrastim Patent Dispute GlobeNewswire
Jul-19-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jul-12-19 12:13PM  Top Ranked Momentum Stocks to Buy for July 12th Zacks
Jul-08-19 04:51PM  Why Deutsche Bank, Intra-Cellular Therapies, and Coherus BioSciences Slumped Today Motley Fool -13.30%
01:30PM  Here's Why Coherus BioSciences Is Falling Today Motley Fool
10:44AM  Are Investors Undervaluing Coherus BioSciences, Inc. (NASDAQ:CHRS) By 20%? Simply Wall St.
09:30AM  Coherus BioSciences Announces Unaudited Second Quarter 2019 UDENYCA® Net Sales of $79 Million to $84 Million GlobeNewswire
09:00AM  Coherus BioSciences to Report Second Quarter Financial Results on August 1st GlobeNewswire
Jul-01-19 09:30AM  Coherus BioSciences Production Exceeds Four-Hundred Thousand UDENYCA® (pegfilgrastim-cbqv) Pre-Filled Syringes GlobeNewswire
Jun-27-19 09:00AM  Coherus BioSciences (CHRS) Upgraded to Strong Buy: Here's Why Zacks
Jun-21-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jun-14-19 05:59PM  Hedge Funds Have Never Been This Bullish On Coherus Biosciences Inc (CHRS) Insider Monkey
May-23-19 10:38AM  Amgen (AMGN) Offers to Acquire Drug Discovery Platform Zacks
09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
May-22-19 09:55AM  Did Coherus BioSciences's (NASDAQ:CHRS) Share Price Deserve to Gain 29%? Simply Wall St.
09:30AM  Coherus BioSciences Management to Present at Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-21-19 10:51PM  Edited Transcript of CHRS earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-13-19 11:30AM  2 Drug Stocks to Buy as Health Care Suffers, According to JPMorgan Barrons.com
May-09-19 07:54PM  Coherus BioSciences, Inc. (CHRS) Q1 2019 Earnings Call Transcript Motley Fool
05:35PM  Coherus BioSciences (CHRS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:24PM  Coherus BioSciences: 1Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and First Quarter 2019 Financial Results GlobeNewswire
May-08-19 04:04PM  Did Hedge Funds Drop The Ball On Coherus Biosciences Inc (CHRS) ? Insider Monkey
May-02-19 05:00PM  Coherus BioSciences and Amgen Settle Trade Secrets Action GlobeNewswire
09:30AM  Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences GlobeNewswire
Apr-26-19 06:58AM  Moving Average Crossover Alert: Coherus BioSciences Zacks
Apr-25-19 09:27AM  The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences Zacks
Apr-24-19 09:11AM  5 Biotech Stocks Defying the Medicare-for-All Scare Zacks
Apr-19-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Apr-09-19 08:41AM  Coherus (CHRS) Catches Eye: Stock Jumps 6.9% Zacks -5.87%
Apr-08-19 04:32PM  Why Sony, AMC Entertainment Holdings, and Coherus BioSciences Jumped Today Motley Fool +6.90%
01:04PM  Here's Why Coherus BioSciences Popped Today Motley Fool
Apr-07-19 09:27AM  Read This Before Buying Coherus BioSciences, Inc. (NASDAQ:CHRS) Shares Simply Wall St.
Apr-05-19 04:00PM  Coherus BioSciences Announces Unaudited First Quarter 2019 UDENYCA Net Sales GlobeNewswire
08:30AM  Coherus BioSciences to Report First Quarter Financial Results on May 9th GlobeNewswire
Mar-28-19 09:30AM  Coherus BioSciences Management to Present at H.C. Wainwright & Co. Global Life Sciences Conference GlobeNewswire
Mar-22-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire -7.61%
Mar-19-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Mar-18-19 09:30AM  Coherus BioSciences Appoints Thomas Fitzpatrick Chief Legal Officer GlobeNewswire
Mar-05-19 08:24PM  Edited Transcript of CHRS earnings conference call or presentation 28-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
08:30AM  New Research: Key Drivers of Growth for American Tower Corporation (REIT), Lowe's Companies, Mimecast, Live Nation Entertainment, Intercept Pharmaceuticals, and Coherus BioSciences Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-28-19 07:10PM  Coherus BioSciences Inc (CHRS) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:30PM  Coherus BioSciences Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-26-19 09:30AM  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March GlobeNewswire -6.55%
Feb-22-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Feb-14-19 09:30AM  Coherus BioSciences to Report Fourth Quarter and Full Year 2018 Financial Results on February 28th GlobeNewswire
Feb-11-19 02:46PM  Here's Why Coherus BioSciences Rose 48.7% in January Motley Fool
Feb-07-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jan-25-19 12:00PM  Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgens Humira Biosimilar Formulation GlobeNewswire +6.54%
Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte-colony stimulating factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Its clinical-stage product candidates include immunology, anti-tumor necrosis factor biosimilar candidates, CHS-1420 for adalimumab and CHS-0214 for etanercept, which has completed Phase III clinical programs; ophthalmology biosimilar candidates, CHS-3351 for ranibizumab and CHS-2020 for aflibercept that is in preclinical development; and CHS-131, small molecule therapeutic candidate and other metabolic conditions. Coherus BioSciences, Inc. has collaboration and license agreements with Daiichi Sankyo Company, Limited; Baxalta Incorporated; Baxalta US Inc.; Baxalta GmbH; and Selexis SA. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Viret Jean-FredericChief Financial OfficerFeb 19Option Exercise10.053,15931,74850,000Feb 21 06:16 PM
Viret Jean-FredericChief Financial OfficerFeb 19Sale22.333,15970,55246,841Feb 21 06:16 PM
Anicetti Vincent RChief Operating OfficerFeb 18Option Exercise7.605,00038,00160,496Feb 20 04:07 PM
Anicetti Vincent RChief Operating OfficerFeb 18Sale21.6410,000216,39052,996Feb 20 04:07 PM
Anicetti Vincent RChief Operating OfficerJan 17Option Exercise7.605,00038,00165,496Jan 22 04:06 PM
Anicetti Vincent RChief Operating OfficerJan 17Sale19.5910,000195,93157,996Jan 22 04:06 PM
Viret Jean-FredericChief Financial OfficerJan 15Option Exercise10.056,31863,49653,159Jan 17 04:11 PM
Viret Jean-FredericChief Financial OfficerJan 15Sale19.856,318125,42446,841Jan 17 04:11 PM
HEALY JAMESDirectorJan 12Option Exercise12.3720,000247,40070,086Jan 13 04:45 PM
HEALY JAMESDirectorJan 09Option Exercise5.0249,994251,00050,086Jan 13 04:45 PM
Anicetti Vincent RChief Operating OfficerDec 16Option Exercise2.502,5006,25121,826Dec 18 04:28 PM
Anicetti Vincent RChief Operating OfficerDec 16Sale18.692,50046,72519,326Dec 18 04:28 PM
Lanfear Dennis MPresident & CEONov 21Sale18.5612,500231,960446,684Nov 25 04:03 PM
Viret Jean-FredericChief Financial OfficerNov 20Option Exercise10.053,15931,7486,462Nov 22 04:09 PM
Lanfear Dennis MPresident & CEONov 20Sale18.00825,00014,850,000459,184Nov 22 06:56 PM
Viret Jean-FredericChief Financial OfficerNov 20Sale19.593,15961,8723,303Nov 22 04:09 PM
Viret Jean-FredericChief Financial OfficerNov 18Sale18.883,11258,7573,303Nov 20 04:22 PM
Anicetti Vincent RChief Operating OfficerNov 14Option Exercise2.502,5006,25121,810Nov 18 04:10 PM
Anicetti Vincent RChief Operating OfficerNov 14Sale19.262,50048,15019,310Nov 18 04:10 PM
Viret Jean-FredericChief Financial OfficerOct 18Sale19.021,38826,4006,385Oct 22 04:06 PM
Viret Jean-FredericChief Financial OfficerOct 16Option Exercise10.053,15931,74810,932Oct 18 04:05 PM
Viret Jean-FredericChief Financial OfficerOct 16Sale19.003,15960,0217,773Oct 18 04:05 PM
Anicetti Vincent RChief Operating OfficerOct 14Option Exercise2.502,5006,25121,810Oct 16 04:08 PM
Anicetti Vincent RChief Operating OfficerOct 14Sale18.402,50046,00019,310Oct 16 04:08 PM
Viret Jean-FredericChief Financial OfficerSep 23Sale21.7874016,1177,773Sep 25 04:05 PM
Viret Jean-FredericChief Financial OfficerSep 18Option Exercise10.053,15931,74811,672Sep 20 04:05 PM
Viret Jean-FredericChief Financial OfficerSep 18Sale20.443,15964,5608,513Sep 20 04:05 PM
Anicetti Vincent RChief Operating OfficerSep 16Option Exercise2.502,5006,25121,810Sep 18 04:05 PM
Anicetti Vincent RChief Operating OfficerSep 16Sale20.032,50050,07519,310Sep 18 04:05 PM
Viret Jean-FredericChief Financial OfficerAug 21Option Exercise10.056,31863,49614,831Aug 23 04:05 PM
Viret Jean-FredericChief Financial OfficerAug 21Sale21.716,318137,1548,513Aug 23 04:05 PM
Viret Jean-FredericChief Financial OfficerAug 19Sale19.043,00057,1208,513Aug 21 04:05 PM
Anicetti Vincent RChief Operating OfficerAug 14Option Exercise2.502,5006,25121,810Aug 16 04:07 PM
Anicetti Vincent RChief Operating OfficerAug 14Sale19.002,50047,50019,310Aug 16 04:07 PM
Anicetti Vincent RChief Operating OfficerJul 15Option Exercise2.502,5006,25121,810Jul 17 04:05 PM
Anicetti Vincent RChief Operating OfficerJul 15Sale19.202,50048,00019,310Jul 17 04:05 PM
HEALY JAMESDirectorJul 02Sale22.61160,0003,617,6001,933,221Jul 02 06:57 PM
HEALY JAMESDirectorJun 28Sale22.05200,0004,410,0002,093,221Jul 02 06:57 PM
HEALY JAMESDirectorJun 20Sale21.37317,1306,777,0682,293,221Jun 24 06:30 PM
Viret Jean-FredericChief Financial OfficerJun 19Option Exercise10.053,15931,74814,672Jun 20 04:05 PM
Viret Jean-FredericChief Financial OfficerJun 19Sale20.283,82677,58711,513Jun 20 04:05 PM
Viret Jean-FredericChief Financial OfficerJun 18Sale19.313,00057,92612,180Jun 20 04:05 PM
Lanfear Dennis MPresident & CEOMay 30Sale19.4932,398631,2821,284,184May 31 08:46 PM
HEALY JAMESDirectorMay 22Sale20.69257,8705,335,3302,610,351May 24 09:44 PM
Viret Jean-FredericChief Financial OfficerMar 20Sale14.923,00044,76213,185Mar 22 04:05 PM